The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Apr. 04, 2018
Applicant:

Cumberland Pharmaceuticals Inc., Nashville, TN (US);

Inventors:

Steven L. Barriere, San Francisco, CA (US);

Arthur Lo, San Francisco, CA (US);

Mathai Mammen, Menlo Park, CA (US);

Philip Worboys, San Mateo, CA (US);

Assignee:

CUMBERLAND PHARMACEUTICALS INC., Nashville, TN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61K 38/14 (2006.01); A61K 9/00 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61K 38/14 (2013.01); A61K 9/0019 (2013.01); A61K 38/12 (2013.01); A61K 47/40 (2013.01);
Abstract

Doses and methods for administering telavancin or a pharmaceutically-acceptable salt thereof to a human patient having an infection caused bysuch as bacteremia, pneumonia, endocarditis, osteomyelitis, a prosthetic joint infection or a complicated skin and skin structure infection, are disclosed. Also disclosed are methods for treating an infection caused byin a human patient using telavancin or a pharmaceutically-acceptable salt thereof. The dose of telavancin administered to the patient is determined, in part, by the weight and creatinine clearance of the patient.


Find Patent Forward Citations

Loading…